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SUMMARY 
An NAD- and GSH-dependent formaldehyde dehydrogenase (formaldehyde: 
NAD* oxidoreductase, EC 1.2.I.Z) was purified from rat and human liver, and the 
properties of these enzymes were compared. The GSH requirement of the enzyme 
obtained from both species could not be replaced by dithiothreitol, CoA or cysteine, 
and NADP could not substitute for NAD. The pH optimum, and the Km of formalde- 
hyde and NAD +, were similar for both rat and human liver formaldehyde dehydro- 
genase. By employing inhibitors such as folic acid and I,Io-phenanthroline, several 
qualitative differences between rat and human liver formaldehyde dehydrogenase 
have been detected. 
The molecular weight of purified human formaldehyde dehydrogenase was es- 
timated at 9oooo. However, the molecular weight of human formaldehyde dehydro- 
genase appeared to be greater than 25o000 when it was determined in preparations 
which also contained alcohol dehydrogenase (alcohol:NAD~ oxidoreductase, EC 
I . I . I . I )  and aldehyde dehydrogenase (aldehyde:NAD + oxidoreductase, EC 1.2.1.3). 
These data suggest that formaldehyde dehydrogenase exists in a complex with other 
proteins or in a polymeric form until the ultimate steps in purification. 
The capacity for NAD-linked formaldehyde oxidation was greater in human 
liver than in rat liver. The possible implications of this are discussed in regard to the 
unique susceptibility of man to methanol poisoning. 
I N T R O D U C T I O N  
Methanol poisoning has been characterized in man as a severe metabolic aci- 
dosis and blindness which occurs 18-24 h after ingestion 1. Because of the latency 
observed prior to the onset of symptoms and because of the reversal of these phenom- 
ena by ethanol administration, this syndrome has been thought to be due to me- 
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tabolic products of methanol rather than methanol per se. Furthermore, this toxicity 
is not observed in lower species with the possible exception of the monkey ~. While 
our knowledge of the first step in the oxidation of methanol in the mammal has in- 
creased considerably over the last decade s the second step in this process, the dispo- 
sition of formaldehyde, has received little attention. Consideration of formaldehyde 
metabolism is important because it may be the toxic metabolite responsible for me- 
thanol poisoning ~. The fact that there is a decided species difference in susceptibility 
to methanol and the lack of information about formaldehyde utilization led to the 
studies reported here. 
A number of aldehyde dehydrogenases have been reported to employ for- 
maldehyde as substrate but analysis of the properties of these enzymes have usually 
been performed with substrates other than formaldehyde4, s. in I955, STRITT~IaTTEI¢ 
ANI) t~;aLL ~ identified a formaldehyde-specific, NAD-dependent dehydrogenase 
(formaldehyde:NAD oxidoreductase, EC 1.2.I.I) in beef liver. The enzyme showed 
a requirement for GSH which was suggested to participate in the reaction rather than 
acting non-specifically to protect protein sulfhydryl groups 6. No studies have been 
performed on human liver or species where methanol metabolism has been examined 
in detail. In addition, formaldehyde is one of the products formed in the demethyla- 
tion of drugs by the hepatic microsomal drug hydroxylation systemL An under- 
standing of the disposition of formaldehyde would extend our knowledge of the utiliza- 
tion of one-carbon fragments generated by the demethylation of many drugs. 
This report documents the presence of an NAD- and GSH-dependent for- 
maldehyde dehydrogenase in rat and human liver, compares certain properties of 
these enzymes, and demonstrates qualitative differences between them. 
M A T E R I A L S  AND M E T H O D S  
Chemicals 
NAD (Grade III), NADP, cytoehrome c (Type II1), DEAE-cellulose, CM-cel- 
lulose, Sephadex G-zoo, bovine serum albumin, yeast alcohol dehydrogenase, calcium 
phosphate gel, GSH, Iolic acid, and i,Io-phenanthroline were purchased from Sigma 
Chemical Company. Pyrazole was purchased from K and K Laboratories, Inc. Oval- 
bumin and myoglobin were purchased from Nutritional Biochemical Company. 
Methotrexate was a gift from Lederle Laboratories. All other reagents were employed 
in the highest purity available. 
Source of li',,er 
Rat livers were obtained from male Holtzman rats (250 g). Human livers were 
obtained at autopsy, not later than Io h post mortem. In all instances the case history 
and gross pathological examination indicated the livers to be free of disease. Similar 
results were obtained when liver from either sex was employed and when fresh human 
liver was examined. Fresh human liver was obtained from a 5o-year-old female who 
had died of a stroke. Artificial ventilation and extracorporeal perfusion had been 
instituted for I h prior to removal of a portion of the liver. 
EH-~V~IH! ctssays 
One unit of enzyme activity is defined as the amount of enzyme which cata- 
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lyzes the reduction of i /,mole of NAD per min under the conditions described. 
Specific activity is expressed as units per mg protein. 
Formaldehyde dehydrogenase. Formaldehyde dehydrogenase activity was 
determined spectrophotometrically by measuring the rate of reduction of NAD at 
34 ° n m  on a Gilford Model 2000 spectrophotometer. All determinations were carried 
out at 22 °. The reaction mixture contained in a final volume of I ml: enzyme; NAD, 
I/~mole; GSH, I #mole; formaldehyde, o.12/Jmole; and phosphate buffer 28, 50 raM, 
pH 8.o. 
Alcohol dehydrogenase. Alcohol dehydrogenase activity was determined spec- 
trophotometrically as described for formaldehyde dehydrogenase. The reaction mix- 
ture contained in a final volume of I ml: enzyme, ethanol, ioo #moles; NAD, 2 
/~moles; and glycine NaOH buffer, 37-5 raM, pH 1o.o. 
Aldehyde de~,drogenase. Aldehyde dehydrogenase activity was determined 
spectrophotometrically as described for formaldehyde dehydrogenase. The reaction 
mixture contained in a final volume of I ml: enzyme, acetaldehyde (or benzaldehyde 
when indicated in the text), IO #moles; pyrazole, I ,umole; NAD, 2 /~moles; phos- 
phate buffer2L 50 raM, pH 8.0. 
Purification of rat liver formaldehyde dehydrogenasc 
Preparation of hepatic cytosol fraction. It  was determined in preliminary ex- 
periments that greater than 90% of the total activity of formaldehyde dehydrogenase 
resided in cytosol fractions of rat and human liver homogenates. Rats were decapi- 
tated, the livers were rapidly removed and placed in an ice-cold solution of o.oi M 
phosphate buffer 2s, pH 7.4, containing o.ooi M disodium EDTA and o.oooz M dithio- 
threitol (Medium A). All procedures for the preparation of the enzyme were carried 
out at 0-4 °. About 30o ml of a 50% (w/v) homogenate were prepared in Medium A 
with a Waring blender (210o0 rev./min, 45 see). The homogenate was centrifuged at 
12500 >~g for 20 min. The supernatant fluid containing mierosomes and cytosol was 
diluted with Medium A to 300 ml and centrifuged in a Spinco Model L ultracentrifuge 
at 785oo xg  for 2 h using a Type 3 ° rotor. The microsomes were discarded and the 
cytosol was diluted with Medium A to about 30 mg protein per ml. A portion of the 
cytosol was dialyzed against IOO times its volume of Medium A and used for analysis of 
formaldehyde dehydrogenase. The rest was employed for other purification pr-ce- 
dures. 
Ammonium sulfate fractio~ation. An NAD-, GSH-dependent formaldehyde 
dehydrogenase was precipitated between 50 and 700/0 (NH4)2SQ saturation. Solid 
(NH4)2SQ was qowly added to obtain the appropriate concentration and the pH 
was maintained at 7-4 by the addition of small amounts of NH4OH. The 5o-7O~o 
(NH4)~SO~ precipitate was brought to ioo ml (3 ° mg protein per hal) in Medium A and 
dialyzed for 12 h against IO 1 of Medium A prior to treatment with an ethanol 
chloroform mixture. 
Ethanol-chloroform fractionatio~. Most of the hemoglobin is removed by slowly 
adding with stirring 2 ml of a mixture of 95% ethanol and chloroform (2 : i, by vol.) 
to each IO ml of dialyzed enzyme preparation. This mixture was centrifuged at 12 5oo 
xg  for 20 min and the resulting supernatant fluid was dialyzed for 12 h against IO 1 
of Medium A. This preparation (about 20 mg protein per ml) was used for DEAl';- 
cellulose chromatography. 
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Chromatography on DEAE-cellulosc. The enzylne preparation was applied to a 
column of DEAE-cellulose (5 cm >~, 45 cm), which had been previously equilibrated 
with Medium A. Elution was effected with a linear gradient of KC1 (o to o.5 M) in 
Medium A. The flow rate was adjusted to 6o ml/h and 2o-ml fractions were (ollected. 
Chromalographv on ,ltydro.~ylapalite. Certain fractions from DEAE-cellulose 
chronmtography containing formaldehyde dehydrogenase and small amounts of 
alcohol dehydrogenase were pooled and applied to a colunm of hydroxylapatite 
(2cm ~i lO cm) which had been equilibrated previously with Medium A. Stepwise elution 
with phosphate buffer (o.oI o.15 M), pH 7.4 '-'s, containing o.ooI M EDTA and o.oooI 
I~1 dithiothreitol was employed. The flow rate was adjusted to Io ml/h and 5-ml frac- 
tions were colleeted. 
Purification of human liver jbrmaldehyde dchydrogc~u~sc 
Preparation of hepatic homogenatc. Autopsy samples of human liver were ob- 
tained, and homogenized as described for rat liver. A hepatic cytosol fraction was 
prepared (as described for rat liver) from a small portion of the homogenate. The 
major portion was treated with an ethanol- chloroform mixture. 
Ethanol-chloroform fracltoJzat[ou. The homogenate was treated with ethanol- 
chloroflwm (2:I  by vol.), in the same manner as that described for the rat liver 
cvtosol. The resulting mixture was centrifuged at 125oo Xg for 2o rain and the super- 
natant was dialyzed for 12 h against 5 1 of Medium A. The dialysis procedure was 
repeated once more, and the preparation (23 oml,  14 nlg protein per ml) was then 
subjected to (NH4)2SO4 fractionation. 
Ammonium sulfalcfractionatiou. An NAD- and GSH-dependent formaldehyde 
dehydrogenase was precipitated between 50 and 70°/6 (NH4)~SO4 saturation. Solid am- 
monium sulfate was employed. This step was carried out as described for the rat liver 
enz\:ITle.  
Chromatography on DEAE-cellulose. The enzyme preparation after ammonium 
sulfate fraetionation was applied to a DEAE-cellulose column (2.5 cm x 25 cm) previ- 
ously equilibrated with Medium A and was eluted with a linear gradient of KCI 
(o 0.2 M) in Medium A. The flow rate was adjusted to 3 ° ml/h and Io-ml fractions 
were collected. Certain fractions containing formaldehyde dehydrogenase activity, 
along with alcohol dehydrogenase and aldehyde dehydrogenase aetivity, were pooled 
and dialyzed for 12 h against 5 1 of O.Ol M phosphate buffer, pH 7.1% containing 
o.ooi M EDTA and o.ooo1 M dithiothreitol prior to treatment with calcium phos- 
phate gel. 
AdsorDtion on calcium phosphate gel. Calcium phosphate gel was added to the 
enzyme preparation obtained by DEAE-cellulose chromatography (2 mg dry weight 
calcium phosphate gel per mg protein). This mixture was stirred for 2o rain at o ° and 
centrifuged at lOOOOXg for lO rain. The supernatant, containing formaldehyde 
dehydrogenase and some alcohol dehydrogenase activity was removed and stored. 
The pellet, consisting of protein adsorbed on calcium phosphate gel, was suspended 
in io ml of 0.05 M phosphate buffer, pH 7.128, containing o.ooI M EDTA and o.oooi 
M dithiothreitol and stirred for 2o rain prior to centrifugation at IOOOO ×g for m min. 
This procedure was repeated once more and the three supernatants containing 
formaldehyde dehydrogenase activity and a small amount of alcohol dehydrogenase 
activity were combined. This preparation was concentrated to a volume of 35 ml using 
Biochim, Biophys. Acta, 252 (i97~) 480-5o5 
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a Diaflow Ul t ra f i l t ra t ion  Cell wi th  a io  ooo mol .wt ,  filter. The concen t ra t ed  p repa ra t ion  
was then d ia lyzed  agains t  3.5 1 of phospha te  buffer 28 (0.0o5 M, p H  7.0) conta in ing  
o .oo i  M E D T A  and o.oooI  M d i th io th re i to l  (Medium B) pr ior  to c h r o m a t o g r a p h y  on 
CM-cellulose. 
Chromatography on CM-cellulose. The enzyme p repa ra t ion  was appl ied  to a CM- 
cellulose column (2.5 c m x 2 o  cm) which had  been prev ious ly  equi l ib ra ted  with 
Medium B. E lu t ion  with  35o ml of Medium B followed. The flow ra te  was ad ius ted  
to 30 ml per  h and 5-ml fract ions were collected. 
Estimation of molecular weight 
The molecular  weight  of ra t  and  h u m a n  hepa t ic  fo rmaldehyde  dehydrogenase  
was e s t ima ted  by  gel f i l t rat ion on a Sephadex  G-200 column according to the  me thod  
of ANDREWS 8. 
Determination of Michaelis constants 
The K,~ of fo rmaldehyde  and NAD + for ra t  and  human  fo rmaldehyde  dehydro-  
genase was de te rmined  b y  the me thod  of LINEWEAVER ANI) BURK 9. 
Protein determination 
Prote in  was de te rmined  by  the BiureO ° me thod  or by  u l t rav io le t  a b so rp t i on" .  
RESULTS 
Purification of formaldehyde dehydrogenase from rat liver 
The comple te  procedure  for the  purif icat ion of fo rmaldehyde  dehydrogenase  
from ra t  l iver  is summar ized  in Table  I. When  E D T A  and d i th io th re i to l  were used 
th roughou t  the  purif icat ion procedure,  enzyme activity, could be ma in t a ined  at  o-5 ° 
wi thou t  measurable  loss for at  least  3 weeks. 
TABLE I 
P U R I F I C A T I O N  O F  F O R M A L D E H Y D E  D E H Y D R O G E N A S E  F R O M  R A T  L I V E R  
Procedure l'ol. Conch. Total Protein Specific Yield Pt*rification 
(ml) (units~rely units (mg/ml) activity (%,) 
Soluble fraction 300 0.027 8. i 3 o. i 0.0009 I oo i 
50 70% (*NH4)2SO4 ioo  0.067 6.7 30.3 0.0022 83 2.5 
Chloroform- 
ethanol 85 0.o7o 6.0 19.5 o-oo36 74 4 
DEAE-cellulose ioo 0.032 3.2 3 .0 O.OLO7 39 la 
Hydroxylapatite IO 0.024 0.24 0.26 0.0920 3 IO2 
Slight ac t iv i ty  was observed in the  cytosol  of r a t  l iver  when GSH was omi t t ed  
from the reac t ion  mixture .  This is p r o b a b l y  due to the  presence of o ther  a ldehyde  
dehydrogenases  which depend  on N A D  and not  on GSH. The pro te in  which pre- 
c ip i t a t ed  be tween 0 and 5o% (NH4)2SO4 sa tu ra t ion  showed a lmost  equal  ac t i v i t y  
wi th  and wi thout  GSH in the  react ion mix tu re  (Table II) .  However ,  the  prote in  
which p rec ip i t a t ed  be tween 5 ° and  7o% (NH4)2SO4 sa tu ra t ion  showed very  l i t t le  
ac t i v i t y  toward  fo rmaldehyde  if GSH was omi t t ed  from the react ion mixture .  
F o r m a l d e h y d e  dehydrogenase  ac t i v i t y  in all f ract ions was ca lcula ted  b y  sub t rac t ine  
Bioch.im. Biophys, Acta, 252 (i97 I) 489 505 
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TABLt.; 1 [ 
F O R M A L D E H Y D E  O X I D A T I O N  I N  R A T  L I V E R  
Soluble fraction 
o 50% (NH4)2S()~ 
5o-.7o% (NH~)2S()~ 
Chloroform-ethanol t reatnlent  
of 50-7o% (NH4).,SO 4 
• G S H  . G S H  Forma ldehyde  
dehydrogenase ( u n i t s )  * 
o.o35 o . O O , S  o.o27 
o.oi9 0.0[ 4 o.oo5 
o . o 7 i  0 .00 4 0.00 7 
0.070 o.ooo o.o7 o 
* Reaction rate (/,moles NAD reduced per ml per min) in the presence of GSH m i n u s  the rate 
when GSH was omitted. Assay conditions were those described in METHODS. 
t h e  r a t e  of N A D  r e d u c t i o n  in t h e  a b s e n c e  of G S H  f rom t h e  r a t e  o b t a i n e d  w h e n  G S H  
was  e m p l o y e d  in t h e  r e a c t i o n .  A f t e r  t r e a t m e n t  w i t h  c h l o r o f o r m - e t h a n o l  t h e r e  was  no  
d e t e c t a b l e  N A D  r e d u c t i o n  if G S H  was  o n f i t t e d  f r o m  t h e  r e a c t i o n  m i x t u r e  ( T a b l e  I I ) .  
1 ; u r t h e r m o r e ,  no  N A D  r e d u c t i o n  was  o b s e r v e d  in t h i s  f r a c t i o n  w h e n  a c e t a l d e h y d e  
was  e m p l o y e d  as  s u b s t r a t e .  T h e s e  o b s e r v a t i o n s  i n d i c a t e  t h a t  s e p a r a t i o n  of r a t  h e p a t i c  
f o r m a l d e h y d e  d e h y d r o g e n a s e  a n d  a l d e h y d e  d e h y d r o g e n a s e  occu r s  a f t e r  c h l o r o f o r m -  
e t h a n o l  t r e a t m e n t  fo l lowing  (NH4).,SO4 f r a c t i o n a t i o n .  T h i s  p r o c e d u r e  offers a m o r e  
e f fec t ive  a n d  r a p i d  m e t h o d  of s e p a r a t i n g  t h e s e  e n z y m e s  t h a n  t h e  p r o c e d u r e s  em-  
p l o y e d  b y  STRITTMATTER AND BALL 6. T h e  r e s u l t s  o b t a i n e d  a f t e r  c h r o m a t o g r a p h y  
on  D E A E - c e l l u l o s e  a re  s h o w n  in Vig. I. T h e  m a j o r i t y  of t h e  a lcohol  d e h y d r o g e n a s e  
a c t i v i t y  was  e l u t e d  p r i o r  to  f o r m a l d e h y d e  d e h y d r o g e n a s e ,  b u t  a n  i n c o m p l e t e  reso-  
l u t i o n  was  o b s e r v e d .  T h e  specif ic  a c t i v i t y  of f o r m a l d e h y d e  d e h y d r o g e n a s e  was  in- 
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Fig. i. DEAE-cellulose chromatography (colunm, 5 ciil x 45 tin) of rat  liver formaldehyde de- 
hydrogenase. Elution was perfornaed with a linear gradient of KC1 (o to 0. 5 M, in o.oi M phosphate 
buffer ~'s, pH 7-4, containing o.ooi M EDTA and o.oooi M dithiothreitol). The flow rate was 
adjusted to 60 ml/h and 2o-nfi fractions were collected. Fractions 28-32 were pooled and chro- 
lnatographed on a hydroxylapat i te  column (Fig. 2). O--O, alcohol dehydrogenase; A- -A,  
formaldehyde dehydrogenase ; ....... protein. 
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Fig. 2. H y d r o x y l a p a t i t e  chromatography (column, 2 c l n x  10 CUl) of rat liver formaldehyde 
dehydrogenase .  Elut ion was  performed stepwise,  wi th  increasing molari ty  of phosphate  buffer 
( o . o i - o . i o  M, pH 7.4 ~s) containing o .oo i  M E D T A  and o .oooi  M dithiothreitol) .  The f low rate 
was  adjusted to io  ml /h  and 5-ml fractions were collected. I - - O ,  alcohol dehydrogenase;  A - - A ,  
formaldehyde  dehydrogenase  ; . . . . . . .  protein. 
creased about I2-fold over that  of the soluble fraction. Certain fractions (28-32) 
which contained formaldehyde dehydrogenase activity and a small amount of alcohol 
dehydrogenase activity were pooled and chromatographed on a hydroxylapati te  
column (Fig. 2). The specific activity of Fraction 22 represents about a I02-fold 
purification of formaldehyde dehydrogenase This fraction was free of alcohol de- 
hydrogenase activity. 
Puri ficatio~z of formaldet~,de dehydrogenase from human liver 
The complete procedure for the purification of formaldehyde hydrogenase from 
human liver is summarized in Table I I I .  The values for human liver cytosol, which 
had been prepared in the same manner as that  of rat  liver, are included for compari- 
T A B L E  I I 1  
P U R I F I C A T I O N  O F  F O R M A L D E H Y D E  D E H Y D R O G E N A S E  Io 'ROM H U M A N  L I V E R  
Procedure Vol. Conch. Total Protein Specific Yield Purification 
(ml) (units/ml) units (mg/ml) activity (°'o) 
Solub le  f r a c t i o n  400 o.o41 16. 4 28.8 o .ooI  ioo  I 
H o m o g e n a t e  a f t e r  
c h l o r o f o r m -  
e t h a n o l  23 ° 0.042 9.7 13.9 0.003 59 3 
5 0 - 7 0 %  
(NH,)2SO 4 5 ° o . I  85 9.3 29.o 0 .006 56 6 
D E A E - c e l l u l o s e  50 O.lO2 5.1 4-4 0.023 31 23 
C a l c i u m  
p h o s p h a t e  gel  35 0.087 3 .0 i .9 0 .045 18 45 
CM-cel lu lose  4 ° 0 .036 1. 4 o .16 0.225 8 225 
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son. When  E D T A  and d i th io th re i to l  were used th roughout  the purif icat ion proce- 
dure,  enzyme ac t iv i ty  could be ma in t a ined  wi thout  measurable  loss a t  o 5 ° for at  
least  3 weeks. 
A considerable  amoun t  of fo rmaldehyde  oxida t ion  occurred in the  cytosol  
fract ion when GSH was omi t t ed  from the react ion mix ture  which is p robab ly  due to 
the  presence of re la t ive ly  non-specific a ldehyde  dehydrogenases .  This is also the case 
when a human  l iver  homogena te  is f rac t iona ted  with chloroform ethanol.  The pro- 
tein which p rec ip i t a t ed  between o and 5o% (NH4).~SO4 sa tu ra t ion  showed almost  
equal  ac t i v i t y  with or wi thout  GSH in the  react ion mixture .  However,  the prote in  
which p rec ip i t a t ed  between 5o and 7o% (NH432SO4 sa tu ra t ion  exh ib i ted  very  l i t t le  
ac t i v i t y  if GSH was omi t t ed  from the react ion mixture .  These results  are shown in 
Table IV. 
TABIA~ IV 
I C O R M A L D E H Y D E  OXIDATION IN HUMAN LIVER 
: GSH ( ;5H l:ormaldehydc 
dehydroge~zase (u~zits) * 
Soluble lraction {).09{) o.o5~ 0.03{) 
Homogenate after chloroform- 
e t h a n o l  o. 1N I O.O 71 o. t 1 o 
o-5o°o (NH4)aS() s o.I{} 3 o.] 74 {}.ooo 
5o-7o°i, (N H~).aS( ) 4 o. I93 o.oj 3 o. rSo 
* Reaction rate (/tmoles NAI) reduced per n)l per Inin} ill the presence {}f GSH menl~s the rate 
when (;SH was omitted..\ssav con(litions were those descril)ed in METHODS. 
The pro te in  which p rec ip i t a t ed  between 50 and ~/0°//o (NH4)~SO4 sa tu ra t ion  con- 
t a ined  a considerable  amoun t  of alcohol dehydrogenase  ac t i v i t y  and at  first appeared  
to contain  only a min imal  amoun t  of a ldehyde  dehydrogenase  ac t iv i ty .  However ,  in 
view of the  fact t ha t  the equi l ibr ium of the alcohol dehydrogenase  react ion lies far in 
favor  of ace ta ldehyde  reduct ion >, it  seeined possible tha t  the following series of reac- 
t ions could be occurr ing:  
('H.~CHO q- NAD~ aldehyde dehydrogenase _~CHaCOO - @ NADH,H~ 
CHaCHO _a N A D H ,  H ~ alcohol dehydrogelIase FILl CM ClM ' 
- - N e t : ~ C H ; C l q ( i - - i l  i17177 --~CHaCOO- -t C H a C H . , - O U  
This series of react ions  would, therefore,  not  yield a net increase in N A D H  and, 
thus, the a ldehyde  dehydrogenase  react ion would be masked  if measurement  of 
N A D H  format ion  was used as the assay. A direct  means  of tes t ing this hypothes is  
was p rov ided  by  the alcohol dehydrogenase  inhibi tor ,  pyrazolela, iL Table V shows 
tha t  the  add i t ion  of pyrazole  to the  5 ° 70% (NH~)~SO4 fraction results  in a profound 
increase in a ldehyde  dehydrogenase  ac t iv i ty .  The concent ra t ion  of pyrazole  employed  
was capable  of comple te ly  inhibi t ing  the  alcohol dehydrogenase  react ion when zo mM 
ethanol  was employed  as subs t ra te  (Table V). Because of this  observat ion,  assays for 
a ldehyde  dehydrogenase  were carr ied out  rou t ine ly  in the presence of z mM pyrazole.  
Aldehyde  dehydrogenase ,  separa ted  from alcohol dehydrogenase ,  was comple te ly  
act ive in the  absence of pyrazole  and, in addi t ion,  a ldehyde  dehydrogenase  ac t iv i ty  
was not  inhib i ted  bv  pvrazole  in concentra t ions  up to 5 raM. When  the 5o-7o °~ 
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T A B L E  V 
T H E  E F F E C T  O F  A L C O H O L  D E H Y D R O G E N A S E  O N  T H E  D E T E R M I N A T I O N  O F  A L D E H Y D E  D E H Y D R O G E N A S E  
A C T I V I T Y  
T h e  e n z y m e  p r e p a r a t i o n  e m p l o y e d  w a s  t h e  5 0 - 7 o %  (NH4)aSO 4 f r a c t i o n  w h i c h  w a s  p r e p a r e d  as  
d e s c r i b e d  in METHODS. 
A ldehyde Alcohol dehydrogenase 
dehydrogenase* zoo m3f  ethanol zo m M  ethanol 
No p y r a z o l e  o .ooo 3 0.o421 o .o166 
P y r a z o l e  (1 raM) 0.0205 o.o213 o 
* /*nIoles of N A D  r e d u c e d  p e r  m g  p r o t e i n  p e r  n l in .  
(NH4)2SO4 fraction was applied to a CM-cellulose column, formaldehyde dehydro- 
genase and aldehyde dehydrogenase are both eluted by 0.005 M phosphate buffer% 
pH 7.0, while alcohol dehydrogenase remained on the column. 
Tile results obtained after applying the 5o-7o% (NH~)2SO4 fraction on a DEAE- 
cellulose column are shown in Fig. 3. This procedure results in a purification of 
formaldehyde dehydrogenase, alcohol dehydrogenase and aldehyde dehydrogenase 
but does not provide for effective separation of these activities. Fractions 16 20 
were combined and treated with calcium phosphate gel. When the gel was washed 
with 0.o5 M phosphate buffer% pH 7.1, a separation of aldehyde dehydrogenase 
from formaldehyde dehydrogenase and alcohol dehydrogenase was seen. Aldehyde 
dehydrogenase and most of the alcohol dehydrogenase remained adsorbed to the gel 
and the final preparation containing formaldehyde dehydrogenase and a small 
amount of alcohol dehydrogenase activity was chromatographed on a CM-cellulose 
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Fig .  3- D E A E - c e l l u l o s e  c h r o m a t o g r a p h y  ( co lumn ,  2.5 c m  x 25 cnl) of h u m a n  l i v e r  f o r m a l d e h y d e  
d e h y d r o g e n a s e .  E l u t i o n  w a s  p e r f o r m e d  w i t h  a l i n e a r  g r a d i e n t  of KCI  (o o.2 M in o . o i  M p h o s p h a t e  
buf fer  ~s, p H  7.4, c o n t a i n i n g  o . o o i  M E D T A  a n d  o .ooo i  M d i t h i o t h r e i t o l ) .  T h e  f low r a t e  w a s  
a d j u s t e d  to  30 n l l / h  a n d  I o - m l  f r a c t i o n s  w e r e  co l l ec ted .  F r a c t i o n s  16 -2o  w e r e  p o o l e d  a n d  t r e a t e d  
w i t h  c a l c i u m  p h o s p h a t e  gel.  e - - O ,  a l coho l  d e h y d r o g e n a s e ;  k - - & ,  f o r m a l d e h y d e  d e h y d r o g e n a s e ;  
[]--LSI, a l d e h y d e  d e h y d r o g e n a s e ;  . . . . . . .  p r o t e i n .  
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Fig. 4. (;M-cellulose-chromatography (cohlmn, 2. 5 CI11 X 20 Cln) of human liver fornmhlchyde dehy- 
drogenase. ]£1ution was performed stepwise with o.oo 5 31 and o.o5o M phosphate buffer as, plI 
7.o, containing o.ool M EDTA and o.ooot M dithiothreitol. The flow rate was adjusted to 3 ° 
ml/h and 5-ml fractions were collected. &--A, alcohol dehydregenase; O--O, formaldehyde 
dehydrogenasc ; ....... protein 
genase  f rom a lcohol  d e h y d r o g e n a s e  ac t iv i ty .  W h e n  F r a c t i o n s  I 3 - 2 o  (Fig. 4) were  
pooled ,  this  p r e p a r a t i o n  had  a specific a c t i v i t y  which  was  a b o u t  225 t imes  t h a t  of the  
hepa t i c  cv tosol .  
Compariso,z of A:AD-linkcd jbrmaldek3,de oxidatio,z i~ rat and humaJz liver soluble 
fraclio~zs 
A c o m p a r i s o n  of N A D - l i n k e d  f o r m a l d e h y d e  o x i d a t i o n  in ra t  and  h u m a n  l iver  
is p r e s e n t e d  in Tab l e  VI.  The  t o t a l  a m o u n t  (un i t s /g  l iver) of f o r m a l d e h y d e  d e h y d r o -  
genase  a c t i v i t y  in h u m a n  l ive r  was found  to be a b o u t  o °' 5 /o h igher  t h a n  t h a t  of ra t  
l iver .  In add i t ion  to this ,  the  c a p a c i t y  for N A D q i n k e d  % r m a l d e h v d e  ox ida t ion  
which  is no t  d e p e n d e n t  u p o n  G S H  was severa l  fold h igher  (un i t s /g  l iver  and  specific 
ac t i v i t y )  in h u m a n  liver.  
TA BL]:. VI 
C O M P A R I S O N  OF N A I ) - L I N l g E I )  F O R M A L I ) E H Y D E  O X I I ) A T I O N  IN R . \T  ANI)  H U M A N  L I V F R  
These studies were performed using hepatic soluble fractions prepared as described in ~IETHODS. 
l:ormaldehydc dchydroge,mse A~o*e-(; S H depeIzdc*# jbrmaldchvdc (m'idatio*z 
U,Hts/g livc'r ,~;pecific activity t'nils/,(* li~]ci; ,qpecific acti,ilv 
Rat o.o54 o.ooo9 o.o16 o.ooo 3 
] ~ t U l l ] a l l  o . o 7 8  o , o o  I o o ,  1 o 2  o . o o  I .~; 
Properties of rat and human liver formaldehyde dehydrogenase 
Pur i f ied  ra t  and  h u m a n  l ive r  f o r m a l d e h y d e  d e h y d r o g e n a s e  p r e p a r a t i o n s  ~ e r e  
e m p l o y e d  for these  s tudies .  The  p r e p a r a t i o n  r ep re sen t ed  102- and  225-fold purif ica-  
t ion  of t he  ra t  and  h u m a n  l iver  enzymes ,  respec t ive ly .  
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Substrate specificity. Both rat and human liver formaldehyde dehydrogenase 
were unreactive towards acetaldehyde and benzaldehyde, in concentrations up to 
IO mM of substrate. These aldehydes have been reported to be good substrates for 
human liver aldehyde dehydrogenaseSOL The Km of formaldehyde for rat  liver 
formaldehyde dehydrogenase was found to be 7.1.1o-6 M, while the Km for the 
human liver enzyme was 8.7-1o * M. The Km of formaldehyde for bovine liver 
formaldehyde dehydrogenase can be calculated to be 5"IO-6 M from the data pre- 
sented bv STRITTMATTER AND BALL 6. The K~  of NAD + for rat  and human hepatic 
formaldehyde dehydrogenase was IO 5 M and 7 '  IO-6 M, respectively. When NADP, 
in concentrations up to 5 raM, was substituted for NAD in the assay of the rat  and 
human liver formaldehyde dehydrogenase, no reaction was detected. No reaction 
was observed when GSH was omitted from reaction mixtures. Furthermore, the 
GSH requirement of both rat  and human liver formaldehyde dehydrogenase could 
not be replaced by cysteine, dithiothreitol or CoA in concentrations up to 5 raM. This 
is consistent with the proposal that  GSH participates directly in the formaldehyde 
dehydrogenase reaction, rather than acting non-specifically to protect protein sulfhy- 
dryl groups ~. 
pH optimum. Both enzymes exhibited broad pH optima. The pH opt inmm for 
rat  liver formaldehyde dehydrogenase was 7.5-8.4 (Fig. 5) while the maximal ac- 
t ivity of human liver formaldehyde dehydrogenase was seen between pH 7.6 and 8.8 
(Fig. 5). These data are in contrast to the sharp pH opt inmm of 8.o reported by 
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Fig. 5- Effect of p H  on the activity of purified ra t  and h u m a n  liver formaldehydedehydrogenase .  
Reactions were carried out  at  22°; reaction mixtures  contained in a final volume of i inl: enzyme, 
o.2 ml; NAD, i /*mole; GSH, i /*mole; formaldehyde, o.12 /,mole; and sodium phospha te  or 
sodium pyrophosphate ,  25 /*moles, adjusted to the desired p H  with  i M HC1. Sodium phospha te  
was employed up to p H  7-5 and sodium pyrophospha te  was used above this p H  value. 
Effect of various inhibitors. The well-known inhibitor of alcohol dehydrogenase, 
I ,Io-phenanthroline,  was studied for its effects on rat  and human liver formaldehyde 
dehydrogenase. Table VI I  shows that  i , Io-phenanthroline had no effect on rat  liver 
formaldehyde dehydrogenase, but does inhibit human liver formaldehyde dehydro- 
genase. Since I ,Io-phenanthroline is a chelating agent, these data suggest that  the 
human liver enzyme is metal-containing, whereas the rat  liver enzyme is not. How- 
Biochim. Biophys. Acta, 252 (1971) 489-5o5 
500 J . I .  GOODMAN, T. R. TEPHI.Y 
ever, a direct inhibi tory  effect of I , I o -phenan th ro l ine  on human  liver fornmldehvde 
dehydrogenase cannot  be ruled out at this time. 
Table VII  shows that  folic acid (zo 4 M) inhibi ted rat  liver formaldehyde 
dehydrogenase bu t  had no effect on the human  liver enzyme indicat ing another  
difference between these enzymes. Methotrexate (5" In 4 M) had no effect on either 
enzyme (Table VII). 
TABLt~; V1 I 
E F F E C T  O F  V A R I O U S  I N H I B I T O R S  O N  P U R I F I E D  R A T  A N D  H U M A N  F O R M A L D E H V I ) E  I ) E H Y D R O G E N A S I ~ ;  
Rates are expressed as/nnoles of NAD reduced per mg protein per rain. Assay conditions werc 
those described in METHODS. 
Rat Human 
Formaldehyde o. 12 o. 1 o 
Formaldehyde plus i, lo-phenanthroline (o. I raM) o. I 2 o.o 7 
Formaldehyde plus 1, lo-phenanthroline (l .o raM) o. t 2 o 
Formaldehyde plus folic acid (o.i raM) o o. to 
Formaldehyde plus methotrexate (o. 5 raM) o. 12 o. i o 
Folic acid and methot rexate  have been shown to be inhibitors of a wide var ie ty  
of dehydrogenases, including malic dehydrogenase, glucose 6-phosphate dehydro- 
genase and alcohol dehydrogenasel<lL Folic acid has been shown to be a zinc che- 
lator 18. However, the possibility tha t  folic acid and methotrexate  inhibi t  alcohol 
dehydrogenase by a chelation mechanism was rejected 17 for several reasons, (z) 
inhibi t ion of dehydrogenase ac t iv i ty  was neither prevented nor reversed by the addi- 
t ion of zinc; (2) the inhibi t ion by folic acid was pH independent .  In  order to chelate 
folic acid with free zinc, tile hydroxyl  group (pK~ 8.3) in the number  4 position of 
folic acid must  be ionized. Thus, if folio acid inhibi ted by chelation, inhibit ion should 
have been greater at higher pH values;  (3) methotrexate,  which has little chelating 
potent ia l i ty ,  was as effective as folic acid in inhibi t ing alcohol dehydrogenase. There- 
fore, the mechanism of dehydrogenase inhibi t ion produced by folic acid and metho- 
t rexate  remains unclear. However, these results point  to a qual i ta t ive difference be- 
tween rat  and human  liver formaldehyde dehydrogenase. 
Effect of pyrazolc. Since pyrazole has been shown to be a potent  inhibi tor  of 
liver alcohol dehydrogenase1% H it was impor tan t  to examine the effect of this con> 
pound on rat  and human  liver formaldehyde dehydrogenase, lqg. 0 shows that  
pyrazole s t inmlates  the oxidation of formaldehyde by rat liver formaldehyde dehy- 
drogenase, l :ur thermore,  it appears to be capable of subs t i tu t ing  for GSH in the 
formaldehyde dehydrogenase reaction. In contrast  to tile results obtained with rat 
liver formaldehyde dehydrogenase, pyrazole had no effect on 5 out of 6 human  liver 
formaldehyde dehydrogenase preparations.  At a concentrat ion of i raM, pyrazole 
produced a co°{) inhibi t ion of tile rate of formaldehyde oxidation by formaldehyde 
dehydrogenase isolated from one human  liver. In addit ion to indicat ing a further 
difference between rat  and human  liver formaldehyde dehydrogenase, these results 
may  indicate tha t  certain human livers may  contain an atypical  formaldehyde 
dehydrogenase. The presence of atypical  alcohol dehydrogenase in some human  liver 
is well-documented and the atypical  enzyme has been shown to be less sensitive to 
inhibi t ion by pyrazole than the normal enzvnle 19. Imidazole, an isomer of pyrazole, 
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Fig. 6. Effect of pyrazole oi1 purified ra t  liver formaldehyde dehydrogenase. All reaction mixtures  
contained 0.2 ml of enzyme (o.4 mg protein per  ml) and o.12 /,mole of formaldehyde in a final 
volume of I ml: (z) NAD, I #mole;  GSH, I #mole;  (2) NAD, i Hmole; GSH, I /~mole; pyrazole, 
I /nnole; (3) NAD*, i #mole;  pyrazole, i /,mole. When pyrazole and GSH were omit ted from 
reaction mixtures  there was no detectable rate  of NAD reduction. Curves represent  tracings 
taken from the recorder of a Gilford Model 2ooo spectrophotometer .  
Estimation of molecular weight.(a) Human liver formaldehyde dehydrogenase. The 
molecular weight of human liver formaldehyde dehydrogenase was estimated by gel 
filtration through a Sephadex G-2oo column (Fig. 7). The molecular weight of purified 
human liver formaldehyde dehydrogenase was estimated at 9 oooo. However, when a 
relatively crude preparation of human liver formaldehyde dehydrogenase which also 
contained alcohol dehydrogenase and aldehyde dehydrogenase was applied to a 
Sephadex G-2oo column (Fig. 7), formaldehyde dehydrogenase was eluted along with 
aldehyde dehydrogenase soon after blue dextran, in a volume indicating its molecular 
weight to be over 250000. Most of the alcohol dehydrogenase was eluted in a volu- 
me indicating its molecular weight to be 8oooo. The molecular weight of purified 
human liver alcohol dehydrogenase has been reported to be 87 ooo (ref. 20). 
(b) Rat  liver formaldehyde dehydrogenase. The molecular weight of rat  liver 
formaldehyde dehydrogenase was estimated at about ILOOOO by gel filtration through 
a Sephadex G-2oo column (Fig. 7). 
DISCUSSION 
These studies have shown the presence of specific formaldehyde dehydrogenase 
requiring NAD and GSH for activity, in rat  and human liver. A I02-fold purification 
of formaldehyde dehydrogenase from rat  liver and a 225-fold purification of for- 
maldehyde dehydrogenase from human liver was achieved. 
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Fig. 7. Est imat ion of the nlolecular weight of rat  and h u m a n  liver formaldehyde dehydrogenase.  
A Sephadex G-2oo coluinn (2 cm < 5 ° cm) was calibrated with six crystalline proteins. The mole- 
cular weights of the crystalline proteins were those given by A:,'DREXVS '~. The elution volume of a 
4-fold purified rat  liver formaldehyde dehydrogenase preparat ion (obtained after chloroform- 
ethanol t rea tment ,  Table 1) was measured, and the molecular weight was est imated to be i to ooo. 
The elution volume of a purified hunlan liver formaldehyde dehydrogenase preparat ion (obtained 
after  CM-cellulose chromatography,  Table I l l )  and a crude human  liver formaldehyde dehydro- 
genase prepara t ion obtained after ammoniunl  sulfate fractionation, Table I l l  were measured. 
The molecular weights of the enzyme in purified and crude preparat ions  were est imated at 0oooo 
and over 250000, respectively. I'e elution volume, I'o -- void voluine (62 ml). 
Rat and human hepatic formaldehyde dehydrogenase were found to be similar 
in several aspects. Both enzymes were unreactive towards acetaldehyde and benzal- 
dehyde, substrates which are known to react favorably with human liver aldehyde 
dehydrogenaseS, 1°. In addition, the GSH requirement of tile enzyme obtained from 
both species could not be replaced by dithiothreitol, CoA or cysteine, and NADP 
was not capable of replacing NAD. Tile Km of formaldehyde was similar for both 
rat and human liver enzymes; 7.I.  lO " M and 8 .7  IO -6 M, respectively. The K,,, for 
NAD ~ was IO -5 and 7" IO-6 M for the rat and human liver enzyme respectively, and 
the pH optimum of rat hepatic formaldehyde dehydrogenase was between 7.5 and 
8.4, while the human liver enzyme has a pH optimum which was slightly broader and 
higher, 7.0-8.8. This contrasts with the sharp pH optinmm of 8.0, that has been 
reported for beef liver formaldehyde dehydrogenase ~ and to a pH optimum between 0 
and IO reported for human liver aldehyde dehydrogenase. 
Several qualitative differences were noted between rat and hunmn liver 
formaldehyde dehydrogenase. I,Io-Phenanthroline had no effect on the rat liver 
enzyme, but did inhibit lmman liver formaldehyde dehydrogenase activity. Since 
I,zo-phenanthroline is a chelating agent, these data suggest that the enzyme from 
human liver is metal-containing. However, a rather high concentration (I raM) of 
o-phenanthroline was required to inhibit the enzyme and, therefore, the inhibition 
may not necessarily have been due to chelaton of a metal. Folic acid inhibited rat 
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liver formaldehyde dehydrogenase, but  had no effect on the human liver enzyme, 
whereas methotrexate  had no effect on either enzyme. 
Pyrazole, the potent inhibitor of liver alcohol dehydrogenase13,14 was examined 
for its effect on formaldehyde dehydrogenase. Contrary to expectations, pyrazole 
stimulated purified rat  liver formaldehyde dehydrogenase activity and it appeared 
to be capable of substituting for GSH in the reaction. I t  is possible that  formaldehyde 
reacts with pyrazole to form N-hydroxymethylpyrazole,  analogous to the reaction of 
formaldehyde with amino and imino groups ~1, which then serves as a substrate for 
rat  liver formaldehyde dehydrogenase. In contrast to the results obtained with the 
rat  liver enzyme, pyrazole had no effect on 5 out of 6 human liver formaldehyde 
dehydrogenase preparations. However, in a concentration of I mM, pyrazole did 
produce a 2o% inhibition of formaldehyde dehydrogenase purified from one human 
liver. This suggests the existence of an atypical human liver formaldehyde dehydro- 
genase in certain individuals. VON WARTBURG AND SCHURCH 19, have reported the 
existence of atypical human liver alcohol dehydrogenase in 2o% of a Swiss and 4% 
of a London population. The typical and atypical alcohol dehydrogenase enzymes 
differed in their susceptibility to inhibition by pyrazole. At an ethanol concentration 
of 1.6. io ~ M, pyrazole (4" IO-5 M) inhibited normal alcohol dehydrogenase by 5o°/o 
while the atypical enzyme was inhibited by 86% 19 . In the current study, the human 
liver formaldehyde dehydrogenase preparation which was inhibited by pyrazole was 
as sensitive to inhibition by I ,Io-phenanthroline as was the formaldehyde dehvdro- 
genase preparation which was not inhibited by pyrazole. This is in contrast to studies 
done on alcohol dehydrogenase 19 where the I~0 for o-phenanthroline was 6. 7 . io- ~ M 
for the normal enzyme and 3.3"IO-~ M for the atypical enzyme. However, at this 
point one cannot conclusively state that  an atypical human liver formaldehyde 
dehydrogenase exists. 
Pyrazole was shown to be useful in the study of aldehyde dehydrogenase when 
this enzyme is contaminated by alcohol dehydrogenase. In the presence of alcohol 
dehydrogenase, aldehyde dehydrogenase activity is masked due to the cycling of 
pyridine nucleotides. Pyrazole inhibits alcohol dehydrogenase without affecting 
human hepatic aldehyde dehydrogenase and, thus, provides a means of determining 
the actual amount of aldehyde dehydrogenase in preparations containing a high 
level of alcohol dehydrogenase activity. 
Formaldehyde dehydrogenase, aldehyde dehydrogenase, and alcohol dehydro- 
genase are 3 functionally related enzymes. Aldehydes serve as substrates for these 
enzymes and a product of the alcohol dehydrogenase reaction, acetaldehyde, is a 
substrate for aldehyde dehydrogenase. I t  is quite interesting that  these human liver 
dehydrogenases remained together after a variety of purification procedures. Only 
by  employing a procedure involving adsorption of calcium phosphate gel between 
chromatography on DEAE-cellulose and on CM-cellulose columns was formaldehyde 
dehydrogenase freed from alcohol dehydrogenase and aldehyde dehydrogenase. The 
molecular weight of the purified human liver formaldehyde dehydrogenase was estimated 
at 9oooo. However, when a relatively crude preparation of truman liver formaldehyde 
dehydrogenase which also contained alcohol dehydrogenase and aldehyde dehydro- 
genase was applied to a Sephadex G-2oo column, formaldehyde dehydrogenase was 
eluted in a volume indicating its molecular weight to be over 25oooo. The aldehyde 
dehydrogenase and about lO% of the alcohol dehydrogenase present in these prepara- 
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tions were also eluted in the same volume as formaldehyde dehydrogenase. The re- 
mainder of the alcohol dehydrogenase was eluted in a volume indicating its molecular 
weight to be about 8oooo. The molecular weight of purified human liver alcohol 
dehydrogenase has been reported to be 87ooo. These data suggest the possibility 
that formaldehyde dehydrogenase, alcohol dehydrogenase and aldehyde dehydro- 
genase exist in a nmltifunctional enzyme complex within the soluble fraction of the 
human hepatic cell. This would explain the difficult}, encountered in isolating these 
dehydrogenases and the observation that in a purified preparation the molecular 
weight of formaldehyde dehydrogenase was estimated at 9oo0o, while in relatively 
crude preparations in which alcohol dehydrogenase and aldehyde dehydrogenase were 
also present the molecular weight of formaldehyde dehydrogenase was estimated at 
over 25ooo0. The physical association of enzymes located in the cytosol as nmlti- 
functional enzyme complexes has been reported to exist in bacteria 22- 24. It is possible 
that this occurs in mammals, also. However, it is also possible that formaldet~yde 
dehydrogenase dissociates into subunits during the final stages of the purification 
procedure and that this accounts for the discrepancy in molecular weight between 
crude and purified preparations. 
A low capacity of human liver to oxidize formaldehyde could have at least 
partially explained the unique susceptibility of man to methanol poisoning. This was 
not the case. The total amount (units/g liver) of formaldehyde dehydrogenase in hu- 
man liver was found to be about 5o~)'o higher than in rat liver. In addition, the capa- 
city for NAD +-linked formaldehyde oxidation which is not dependent upon (iSH was 
several fold higher (in terms of units/g liver and specific activity) in human liver as 
compared to rat liver. While it is possible that there are other pathways for formalde- 
hyde disposition which are operative to a greater extent in rat liver, on the basis of 
these studies it appears that the conversion of formaldehyde to formate can proceed 
more readily in lmman liver than in rat liver. Perhaps, the explanation for the suscep- 
tibility of inan to methanol poisoning lies in the formate utilization step. Previous 
studies from tiffs laboratory have shown a minimal capacity for hydrogen peroxide 
generation in human liver 2s. If formate oxidation relies on a peroxidative mechanism 
as has been suggested2S, ''7 the toxicity of methanol may be explained on the basis of a 
lack of peroxidative oxidation in human liver. 
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